Modeling Hypertrophic Cardiomyopathy: Mechanistic Insights and Pharmacological Intervention

Diogo Mosqueira1, James G W Smith2, Jamie R Bhagwan1

  • 1Department of Stem Cell Biology, Centre of Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK.

Insights

Hypertrophic cardiomyopathy (HCM) research utilizes various models to understand cardiac dysfunction. Human pluripotent stem cell (hPSC) models offer new insights into HCM mechanisms and therapeutic development.

Area of Science:

  • Cardiovascular Research
  • Genetics and Molecular Biology
  • Stem Cell Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease characterized by cardiac dysfunction.
  • Mutations in sarcomeric genes are frequently associated with HCM pathogenesis.
  • Existing models like tissue explants and isolated cells have revealed disease hallmarks but have limitations.

Purpose of the Study:

  • To compare recent advancements in understanding HCM mechanisms across different experimental models.
  • To highlight consistencies and discrepancies in findings from various HCM models.
  • To explore how model-based insights inform the development of novel HCM therapeutics.

Main Methods:

  • Review and comparison of data from diverse HCM models, including traditional systems and human pluripotent stem cell (hPSC)-based models.
  • Analysis of studies investigating sarcomeric gene mutations and their impact on cardiac function.
  • Evaluation of therapeutic strategies targeting metabolism, contraction, and rhythm in HCM.

Main Results:

  • Various models have identified key features of hypertrophic cardiomyopathy (HCM).
  • Human pluripotent stem cell (hPSC) models provide complementary data and challenge previous findings.
  • Similarities and differences in HCM mechanisms are observed across different modeling systems.

Conclusions:

  • Different experimental models offer valuable, sometimes contrasting, insights into hypertrophic cardiomyopathy (HCM) pathogenesis.
  • Human pluripotent stem cell (hPSC) models are emerging as powerful tools for HCM research.
  • Understanding HCM mechanisms through diverse models is crucial for designing effective therapeutic interventions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
426
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
369
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
490
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
486
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
251
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
300